Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia

Bibliographic Details
Main Author:	Michael H. Davidson
Format:	Article
Language:	English
Published:	Elsevier 2015-04-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396415000675

Similar Items

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia
by: O. Samuelsson, et al.
Published: (2013-01-01)

Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
by: Jonathan E. Campbell
Published: (2021-04-01)

Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice
by: Robin van Eenige, et al.
Published: (2021-01-01)

Dyslipidemia in Obesity: Mechanisms and Potential Targets
by: Jan Willem F. Elte, et al.
Published: (2013-04-01)

HDL-C as a new therapeutic target in the treatment of dyslipidemia
by: Sahin I
Published: (2012-06-01)

Evaluation of flaxseed formulation as a potential therapeutic agent in mitigation of dyslipidemia
by: Sonali Saxena, et al.
Published: (2014-12-01)

Therapeutic Target Achievement in Type 2 Diabetic Patients after Hyperglycemia, Hypertension, Dyslipidemia Management
by: Ah Young Kang, et al.
Published: (2011-06-01)

Study of therapeutic potential of acid caffeic protocols and diabetes in mice dyslipidemia
by: Vivianne Machado de AraÃjo
Published: (2014)

Glucagon and GLP-1 receptor dual agonism : a therapeutic approach for the treatment of obesity
by: Cegla, Jaimini
Published: (2015)

PCSK9 and its clinical importance with the new therapeutic targets against dyslipidemia
by: Carlos Eduardo dos Santos Ferreira, et al.

Therapeutic strategies targeting oxidative stress to improve dyslipidemia and left ventricular hypertrophy
by: Flávio Reis
Published: (2017-09-01)

Therapeutic strategies targeting oxidative stress to improve dyslipidemia and left ventricular hypertrophy
by: Flávio Reis
Published: (2017-09-01)

Therapeutic potential of Moringa oleifera leaves in chronic hyperglycemia and dyslipidemia: a review
by: Majambu eMbikay, et al.
Published: (2012-03-01)

Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation
by: Fan J, et al.
Published: (2018-02-01)

Intensidad dramática en "Agone"
by: María Teresa Olivera Santos
Published: (2000-12-01)

Agonism and antagonism at the insulin receptor.
by: Louise Knudsen, et al.
Published: (2012-01-01)

Athletics, Gymnastics, and Agon in Plato
Published: (2020)

From the poetic to the platonic 'agon'
by: Nelson de Aguiar Menezes Neto
Published: (2018-12-01)

Beta-Carotene, Glycemic Control And Dyslipidemia In Type 2 Diabetes Mellitus
by: Hayder Ali Mohammed, et al.
Published: (2007-01-01)

Beta-Blockers Show Inverse Agonism to a Novel Constitutively Active Mutant of β1-Adrenoceptor
by: Maruf Ahmed, et al.
Published: (2006-01-01)

Agon Lost – or in Disguise? A Commentary
by: Ballisager Olav
Published: (2019-06-01)

OCCURRENCE OF AGONE ALOSA AGONE IN LAKE SHKODRA, ALBANIA IN SYMPATRY WITH TWAITE SHAD ALOSA FALLAX NILOTICA.
by: RAKAJ N., et al.
Published: (2001-07-01)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
by: Lu-yang Zhang, et al.
Published: (2019-09-01)

Politicizing Skepticism – Agonal Thought for Democracy
by: Daniel Nunes Pereira, et al.
Published: (2016-12-01)

The Agon Motif and the Concept of Movement Culture
by: Renson Roland
Published: (2019-06-01)

Integrating agonism with deliberation: Realising the benefits
by: Knops Andrew
Published: (2012-01-01)

Administrative preventive detention: agonic interpretation
by: Jhomny Urrea
Published: (2016-06-01)

Potential therapeutic effect of Moroccan propolis in hyperglycemia, dyslipidemia, and hepatorenal dysfunction in diabetic rats
by: Nawal El Menyiy, et al.
Published: (2019-11-01)

Therapeutic Effects of Quetiapine and 5-HT1A Receptor Agonism on Hyperactivity in Dopamine-Deficient Mice
by: Fujita, M., et al.
Published: (2022)

Soft TCPTP agonism – Novel target to rescue airway epithelial integrity by exogenous spermidine
by: Carlo eGhisalberti, et al.
Published: (2016-06-01)

The brain strikes back: Hypothalamic targets for peripheral CB1 receptor inverse agonism
by: Daniela Cota
Published: (2017-10-01)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
by: Fisman Enrique Z, et al.
Published: (2006-09-01)

Sports agon and death: the existential nature of correlation
by: S. V. Mogileva
Published: (2015-04-01)

The Evaluation of Chinese Therapeutic Food for the Treatment of Moderate Dyslipidemia
by: Shu Sun, et al.
Published: (2012-01-01)

Platelet reactivity in dyslipidemia: atherothrombotic signaling and therapeutic implications
by: Moua Yang, et al.
Published: (2021-03-01)

Biased agonism: the quest for the analgesic holy grail
by: M. Alexander Stanczyk, et al.
Published: (2018-06-01)

L'agone. Fécondation et incubation artificielles
by: PIROLA E.
Published: (1930-10-01)

The birth of sports from the spirit of agonal eccentricity
by: Koprivica Časlav D.
Published: (2019-01-01)

Agonal Perspectives on Nietzsche's Philosophy of Critical Transvaluation
Published: (2021)

The Agonal Character of Soft Power in Modern Turkey
by: A.S. Isacov
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_7nhg6nilh5ksqfk288mr79e669